Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Aceragen, Inc. (IDRA)
|
Add to portfolio |
|
|
|
| Price: |
$0.59
| | Metrics |
| OS: |
8.42
|
M
| |
|
|
| Market cap: |
$4.99
|
M
| |
|
|
|
Net debt:
|
$4.18
|
M
| |
|
|
|
EV:
|
$9.17
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 1.4 | 0.7 | 0.9 | 16.2 | 0.2 | 0.1 |
| Revenue growth | | -100.0% | 118.7% | -26.6% | -94.4% | 6405.6% | 241.1% | 55.3% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 1.4 | 0.7 | 0.9 | 16.2 | 0.2 | 0.1 |
| Gross margin | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 16.4 | 24.8 | 34.9 | 41.8 | 50.7 | 39.8 | 33.7 | 27.5 |
| General and administrative | 10.0 | 11.9 | 12.5 | 15.4 | 15.6 | 15.1 | 15.4 | 11.3 |
| EBIT | -26.4 | -36.7 | -45.9 | -56.6 | -65.3 | -38.8 | -48.8 | -38.8 |
| EBIT margin | | | -3168.9% | -8549.7% | -7243.8% | -239.3% | -19616.9% | -53084.9% |
| Pre-tax income | 98.1 | -112.7 | -56.5 | -59.9 | -66.0 | -38.4 | -48.6 | -38.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -28.8 | -112.7 | -84.6 | -59.9 | -66.0 | -38.4 | -48.6 | -38.6 |
| Net margin | | | -5839.6% | -9045.5% | -7315.3% | -237.0% | -19500.0% | -52934.2% |
| |
| Diluted EPS | ($0.58) | ($3.33) | ($2.96) | ($2.25) | ($3.35) | ($2.41) | ($0.42) | ($0.47) |
| Shares outstanding (diluted) | 50.1 | 33.8 | 28.5 | 26.6 | 19.7 | 16.0 | 115.1 | 82.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|